Pharmaceutical Business

305 posts

Doctors & Pharma Industry – Part 1 of 2 – Asrar Qureshi’s Blog Post 1217

The blog post by Asrar Qureshi explores the complex relationship between pharmaceutical companies and doctors, emphasizing its dual nature of necessity and ethical risk. It advocates for transparency and independence in education, particularly in the context of Pakistan’s healthcare challenges. The post highlights both issues and contributions of this relationship in improving patient access to treatment.
Share
View Post
  • 6 min

Formation of PharmEx Pakistan – Too Late, Too Little? – Asrar Qureshi’s Blog Post #1123

The Ministry of Commerce in Pakistan is launching PharmEx Pakistan to boost pharmaceutical exports, aiming to increase annual exports from $700 million to $3 billion. This public-private initiative, modeled after India’s Pharmexcil, seeks to enhance regulatory compliance and global visibility for Pakistani pharmaceuticals, while facing challenges in international competitiveness.
Share
View Post
  • 5 min

50 Years of Work and Counting – Asrar Qureshi’s Blog Post #1081

Asrar Qureshi reflects on his 50-year career in the pharmaceutical industry, starting in February 1975. He highlights his journey from a medical representative to executive roles and acknowledges influential mentors like Imtiaz Ahmed Taj and Javed Akhtar. Gratitude for personal growth and the blending of work and life is emphasized throughout his narrative.
Share
View Post
  • 5 min

Disruption of Careers in Pharma Industry – Asrar Qureshi’s Blog Post #1018

Asrar Qureshi’s Blog Post discusses the evolution of career paths in Pakistan’s pharmaceutical industry over the past 40 years. It highlights the shift from MNC-led promotions to local companies hiring laterally, leading to unqualified promotions and ethical challenges. The post emphasizes the industry’s declining appeal as stress and burnout increase among employees despite higher perks and salaries.
Share
View Post
  • 5 min

Medicines Consumption in Pakistan – Asrar Qureshi’s Blog Post #1017

Asrar Qureshi’s blog highlights the thriving yet monopolized pharmaceutical industry in Pakistan, noting a 20% growth in FY 2023-2024. While the availability of medicines has improved, affordability remains a concern amid rising prices. The country faces chronic health issues and environmental challenges, impacting healthcare dynamics and patient access.
Share